40
Participants
Start Date
May 31, 2002
Study Completion Date
September 30, 2002
Tolvaptan
Central Cardiology Medical Clinic, Bakersfield
University of California-San Diego, San Diego
University of Miami/Jackson Memorial Hospital, Miami
Medical Research Institute, Slidell
Androscoggin Cardiology Associates, Auburn
University of Missouri-Kansas City School of Medicine, Kansas City
Saint Louis University, St Louis
Cardiology of Oklahoma, Tulsa
Medical University of South Carolina, Charleston
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY